RxDoctor Payments Data

Kristin Cook, MD

Vascular Surgery · Hackensack, NJNPI 1093976466

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (36.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Penumbra, Inc. accounts for 74.1% of it on its own, with 32 other manufacturers making up the rest. 2025 is the largest year on record at $12,511, 8.1 times the $1,545 reported in 2019. Among vascular surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,641in general payments, 2019–2025

Across 211 payments — averaging $159.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$25K
  • Cook Incorporated$3K
  • Silk Road Medical, Inc.$1K
  • Medtronic$1K
  • Cook Medical LLC$1K
  • Inari Medical, Inc.$437
  • plus $2K from 27 others
$6,010in research payments, 2019–2025

Across 2 payments — averaging $3005.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$6K

What the payments were for

  • Speaking & faculty fees$12,10036%
  • Travel & lodging$10,31031%
  • Food & beverage$11,23133%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,641 in reported general payments places this provider in the 90th percentile of 182 vascular surgery providers in New Jersey.

See all vascular surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$116,053
Medicare patients
740
Services billed
1,146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$11,756
ClopidogrelClopidogrel Bisulfate62$510

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →